3 hours ago | News
Veloxis Pharmaceuticals A/S today announced that it contemplates restructuring the company's operations in order to fully focus its resources on the completion of the development and subsequent commercialization of LCP-TacroT, Veloxis' product candidate for the prevention of organ rejection.
|
3 hours ago | News
CHARLOTTE, N.C. (AP) — Chelsea Therapeutics International Ltd. said Tuesday it may have to make changes to a clinical trial of its drug candidate Northera, potentially delaying its approval.
|
3 hours ago | News
Pfizer Inc. named Olivier Brandicourt as President and General Manager of the Emerging Markets and Established Products Business Units, effective June 1, 2012.
|
3 hours ago | News
Pharmaceutical Product Development, LLC (PPD) today announced that its board of directors has named David Simmons chairman and CEO.
|
23 hours ago | News
InterMune, Inc. today announced that it has reached a definitive agreement with Vidara Therapeutics International Limited to sell its rights to Actimmune® (interferon gamma-1b) in a cash transaction valued at $55 million plus a two-year royalty stream.
|
May 22 | News
WASHINGTON (AP) — The Food and Drug Administration said Monday that a blood thinner from Johnson & Johnson appears to reduce life-threatening blood clots in high-risk patients, although it also increases the risk of internal bleeding.
|
May 22 | News
NEW YORK (AP) — Standard & Poor's Indices said Monday that it is adding the stock of drug developer Alexion Pharmaceuticals Inc. to its S&P 500 index.
|
May 22 | News
Medivation, Inc. and Astellas Pharma Inc. announced that Medivation has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for enzalutamide (formerly MDV3100). The compound has been studied in patients with castration-resistant prostate cancer who have received docetaxel therapy.
|
May 21 | Articles
In recent years, emerging markets have been touted as an affordable and attractive labor pool for the outsourcing of pharmaceutical and biotechnology projects.
|
May 21 | News
Baxter facilities in Halle and Bielefeld, located in Germany's Westfalen region, have been recognized and certified for their capabilities in handling potent pharmaceutical compounds by SafeBridge Consultants, Inc., a leading occupational health and safety consulting firm. Baxter is...
|